Cell>Point Company Profile

01:59 EDT 18th March 2018 | BioPortfolio

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monitoring of cancer, heart, and other diseases. Cell>Point has exclusive license to five drug-development platforms, all from The University of Texas M. D. Anderson Cancer Center in Houston, a world leader in cancer research and care. Information on Cell>Point’s drug candidates, recent press releases, and patents and patent filings can be obtained through its website at The company is headquartered in Centennial, Colo., and has additional offices in San Francisco and Houston.

News Articles [1169 Associated News Articles listed on BioPortfolio]

New tool in cell's invasion machinery may help explain cancer's ability to spread

Scientists have discovered a new tool in the cell's invasion machinery that may help explain cancer's ability to spread. Time-lapse imaging of the worm C. elegans reveals a fleeting protrusion that we...

New book on Cell-Cell Junctions published by CSHLPress

(Cold Spring Harbor Laboratory Press) "Cell-Cell Junctions, Second Edition", published by Cold Spring Harbor Laboratory Press, reviews our understanding of the organization, regulation, and dynamics o...

Have we reached a tipping point with stem cell therapy?

TiGenix NV (NYSE Euronext: TIG) is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes, and a commercialised product. during Biotech And Mon...

3D packaging of DNA regulates cell identity

The ability of a stem cell to differentiate into cardiac muscle (and by extension other cell types) depends on what portions of the genome are available for activation, which is controlled by the loca...

3-D packaging of DNA regulates cell identity

(University of Pennsylvania School of Medicine) A new study suggests that the ability of a stem cell to differentiate into cardiac muscle (and by extension other cell types) depends on what portions o...

From UCSF, New Sequencer Reveals Cancer Blueprints, Cell By Cell

Cells within a single tumor can have a variety of genetic fingerprints. Understanding that variety is likely a key to fighting cancer in the near future. A new biotech firm has developed a device that...

Don't judge a cell by its cover: heterogeneity within early lymphoid progenitors

B-cell differentiation is one of the most recognized examples of the progressive lineage commitment that is distinctive for stem cell systems. However, the characteristics of the stage just before a c...

Researchers Discover that Ribosomes Induce Somatic Cell Pluripotency

NewsResearchers have confirmed that the incorporation of ribosomes into human skin cells will form a new cell mass, and that a lactobacillus-derived cell initialization substance is also the ribosome.

Drugs and Medications [130 Associated Drugs and Medications listed on BioPortfolio]

Everyday clean dandruff [On-Point, Inc]

Drug Facts

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Gel - 32 oz.

Ibuprofen [Preferred Pharmaceuticals, Inc]


Motrin®ibuprofen tablets, usp [Pharmacia & Upjohn Company]

Motrin®Ibuprofen Tablets, USP

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Spray - 16 oz. Spray

PubMed Articles [3358 Associated PubMed Articles listed on BioPortfolio]

Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.

Every animal species has a signature blood glucose level or glycemic set point. These set points are different, and the normal glycemic levels (normoglycemia) of one species would be life threatening ...

A Precise Cdk Activity Threshold Determines Passage through the Restriction Point.

At the restriction point (R), mammalian cells irreversibly commit to divide. R has been viewed as a point in G1 that is passed when growth factor signaling initiates a positive feedback loop of Cdk ac...

Hotspots of De Novo Point Mutations in Induced Pluripotent Stem Cells.

Induced pluripotent stem cells (iPSCs) are generated by direct reprogramming of somatic cells and hold great promise for novel therapies. However, several studies have reported genetic variations in i...

Multi-Parametric Imaging of Hypoxia and Cell Cycle in Intestinal Organoid Culture.

Dynamics of oxygenation of tissue and stem cell niches are important for understanding physiological function of the intestine in normal and diseased states. Only a few techniques allow live visualiza...

Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T Cell Decline and Per-Parasite Pathogenicity.

Pathogen strains may differ in virulence because they attain different loads in their hosts, or because they induce different disease-causing mechanisms independent of their load. In evolutionary ecol...

Clinical Trials [6690 Associated Clinical Trials listed on BioPortfolio]

Weight Set-Point and HDL Concentration in Runners

To investigate the differences in diet, fat cell morphology and lipoprotein metabolism in previously- overweight and naturally lean men and women who ran and who lived sedentary lifestyles...

Localization of Point A in Cervical Cancer

Point A, the major critical point for dose specification of intracavitary brachytherapy, is defined as the crossing of uterine artery and ureter in treatment of cervical cancer. However, t...

A Trial of Point of Care Information in Ambulatory Pediatrics

Does presentation of clinical evidence for decision making at point-of-care improve prescribing patterns in ambulatory pediatrics?

Use of Point-of-care Ultrasound in High Risk Surgical Patients

There is currently a lack of evidence to support the use of perioperative point-of-care ultrasound to assess the outcomes in high surgical patients. Thus, the purpose of this study is to e...

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

The GPPAD-POInT Study is designed as a randomized, placebo-controlled, double blind, multicentre, multinational primary prevention phase IIb study aiming to induce immune tolerance to beta...

Companies [1418 Associated Companies listed on BioPortfolio]


Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monito...

Point Foundation

Point Foundation (Point) is the nation's largest scholarship-granting organization for lesbian, gay, bisexual and transgender (LGBT) students of merit. Point provides financial support, leadership tra...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the ...

Tipping Point Community

Tipping Point Community screens non-profits rigorously to find the most effective groups connecting Bay Area individuals and families to the services and opportunities needed to break the cycle of pov...

BridgeWave Communications

BridgeWave Communications is the leading supplier of high-capacity 4G millimeter wave backhaul and gigabit wireless connectivity solutions. BridgeWave's carrier-grade, point-to-po...

More Information about "Cell>Point" on BioPortfolio

We have published hundreds of Cell>Point news stories on BioPortfolio along with dozens of Cell>Point Clinical Trials and PubMed Articles about Cell>Point for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell>Point Companies in our database. You can also find out about relevant Cell>Point Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record